Search Results - "Jafri, Rabab Z"
-
1
Global epidemiology of invasive meningococcal disease
Published in Population health metrics (10-09-2013)“…Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In…”
Get full text
Journal Article -
2
198-OR: Individual Response of Automated Glycemic Control with the iLet Bionic Pancreas in the Insulin-Only vs. Bihormonal Configuration with the Stable Glucagon Analog Dasiglucagon
Published in Diabetes (New York, N.Y.) (01-06-2020)“…In an outpatient, home-use, random-order, controlled trial we compared automated glycemic control with the iLet bionic pancreas in the insulin-only (IOBP) vs…”
Get full text
Journal Article -
3
Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study
Published in Journal of cystic fibrosis (01-01-2020)“…Cystic fibrosis-related diabetes (CFRD) is the most common extrapulmonary manifestation of cystic fibrosis. The current standard of care for CFRD involves…”
Get full text
Journal Article -
4
Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature
Published in World journal of surgical oncology (17-05-2011)“…Sarcoma encompasses an uncommon group of cancer and the data is insufficient from Pakistan. We report our four years experience of Sarcoma of soft tissues and…”
Get full text
Journal Article -
5
77-OR: First Human Study Testing the iLet, a Purpose-Built Bionic Pancreas Platform
Published in Diabetes (New York, N.Y.) (01-06-2019)“…The Gen3 iLet (iLet) is a purpose-built, fully integrated, bionic pancreas (BP) platform that can operate in a bihormonal, insulin-only, or glucagon-only mode…”
Get full text
Journal Article -
6
Improvements in Glycemic Control Achieved by Altering the tmax Setting in the iLet® Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial
Published in Diabetes therapy (01-07-2021)“…Introduction We investigated the safety of, and glucose control by, the insulin-only configuration of the iLet ® bionic pancreas delivering fast-acting insulin…”
Get full text
Journal Article -
7
Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults
Published in JCI insight (25-07-2019)“…There is growing evidence to suggest that the brain is an important target for insulin action, and that states of insulin resistance may extend to the CNS with…”
Get full text
Journal Article -
8
A Three-Way Accuracy Comparison of the Dexcom G5, Abbott Freestyle Libre Pro, and Senseonics Eversense CGM Devices in an Outpatient Study of Subjects with Type 1 Diabetes
Published in Diabetes (New York, N.Y.) (01-07-2018)“…There are no published studies directly comparing the accuracy of continuous glucose monitoring (CGM) devices in the outpatient setting. We tested the…”
Get full text
Journal Article -
9
Differential Effects of the Insulin-Only and Bihormonal Configurations of the Bionic Pancreas on Mean Glucose and Hypoglycemia during the Daytime and Nighttime
Published in Diabetes (New York, N.Y.) (01-07-2018)“…The bihormonal bionic pancreas (BP) reduced both mean CGM glucose (CGMG) and time in the hypoglycemic range relative to usual care in outpatient studies. We…”
Get full text
Journal Article -
10
Improvements in Glycemic Control Achieved by Altering the t.sub.max Setting in the iLet.sup.® Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial
Published in Diabetes therapy (01-07-2021)“…Introduction We investigated the safety of, and glucose control by, the insulin-only configuration of the iLet.sup.® bionic pancreas delivering fast-acting…”
Get full text
Journal Article